NasdaqCM - Nasdaq Real Time Price USD
Synlogic, Inc. (SYBX)
1.2650
+0.0538
+(4.44%)
At close: June 9 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (1970) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -0.48 | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (1970) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | -0.66 | -0.16 | -0.18 | -0.1 |
EPS Actual | -0.27 | -0.48 | -0.01 | 0.85 |
Difference | 0.39 | -0.32 | 0.17 | 0.95 |
Surprise % | 59.09% | -197.37% | 94.44% | 950.00% |
EPS Trend
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (1970) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (1970) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | 1 | -- |
Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
SYBX | -- | -- | -- | -- |
S&P 500 | 13.13% | 2.46% | 7.55% | 14.08% |
Upgrades & Downgrades
Upgrade | HC Wainwright & Co.: Sell to Neutral | 3/20/2024 |
Downgrade | Chardan Capital: Buy to Neutral | 2/9/2024 |
Downgrade | Leerink Partners: Outperform to Market Perform | 2/9/2024 |
Downgrade | HC Wainwright & Co.: Buy to Sell | 2/9/2024 |
Initiated | Alliance Global Partners: Buy | 12/11/2023 |
Related Tickers
LVTX LAVA Therapeutics N.V.
1.3600
+3.03%
EPIX ESSA Pharma Inc.
1.7000
-0.58%
HLVX HilleVax, Inc.
2.0400
+2.51%
PMVP PMV Pharmaceuticals, Inc.
1.0600
+9.28%
PRTC.L PureTech Health plc
140.52
+0.52%
CRGX CARGO Therapeutics, Inc.
4.6400
-2.32%
KZR Kezar Life Sciences, Inc.
4.4500
+1.14%
IKNA Ikena Oncology, Inc.
1.4700
+3.52%
NERV Minerva Neurosciences, Inc.
1.8400
+1.66%
TBPH Theravance Biopharma, Inc.
10.95
-2.67%